Skip to content
Governance Register

← US public companies

Principia Biopharma Inc.

SEC CIK 1510487 · PRNB · last insider filing 2020-09-28

Directors (from insider filings)

NameCapacity as filedFilings
Machado Patrick Director filed 2019 - 2020
Colowick Alan Director filed 2018 - 2020
Babler Martin Director · President, CEO filed 2018 - 2020
George Simeon Director filed 2018 - 2020
Tomasello Shawn Director filed 2019 - 2020
Lin Shao-Lee Director filed 2019 - 2020
Becker Daniel J. Director filed 2018 - 2020
Smither John W Director filed 2019 - 2019
Akkaraju Srinivas Director filed 2018 - 2019
Shuster Lewis Director filed 2018 - 2019
Usman Nassim Director filed 2018 - 2018
Thompson Peter A. Director filed 2018 - 2018

Officers (from insider filings)

NameTitle as filedFilings
Chai Christopher Y Chief Financial Officer filed 2018 - 2020
Hardiman Roy C. Chief Business Officer filed 2018 - 2020
Goldstein David M Chief Scientific Officer filed 2018 - 2020
Wolff Stefani Senior VP of Strategy and Ops filed 2018 - 2020
Thomas Dolca Chief Medical Officer filed 2019 - 2020
Gourlay Steve Chief Medical Officer filed 2018 - 2018

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.